BIO
Bio-Rad Laboratories Inc
378.90$
-0.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 45.8% | 44.5% | 45.0% | 45.0% | 46.5% | 45.6% | 43.5% | 43.9% | 44.1% | 46.6% | 46.3% | 48.0% | |
| 54.2% | 55.5% | 55.0% | 55.0% | 53.5% | 54.4% | 56.5% | 56.1% | 55.9% | 53.4% | 53.7% | 52.0% | |
| 10.1% | 9.6% | 10.0% | 11.6% | 8.7% | 8.8% | 8.6% | 8.9% | 9.2% | 9.3% | 11.5% | 9.9% | |
| 37.2% | 37.7% | 39.5% | 37.4% | 36.5% | 35.7% | 31.4% | 30.1% | 29.5% | 31.7% | 31.7% | 32.7% | |
| 47.3% | 47.3% | 49.4% | 49.0% | 45.1% | 44.4% | 39.9% | 38.9% | 38.7% | 40.8% | 43.2% | 41.7% | |
| 6.9% | 8.3% | 2.6% | 5.4% | -4.7% | 9.9% | 16.6% | 17.1% | 17.2% | 12.6% | 10.5% | 10.5% | |
| 1.0% | 1.1% | 1.1% | 1.1% | 1.0% | 1.0% | 0.9% | 0.1% | 1.4% | 1.9% | 1.9% | 1.9% | |
| 6.0% | 7.2% | 2.0% | 4.5% | 22.2% | 97.8% | 193.2% | 186.4% | -167.9% | -31.8% | -91.3% | 38.5% | |
| 2.0% | 1.6% | 0.6% | -0.8% | 6.4% | 21.7% | 43.4% | 40.9% | -38.4% | -8.0% | -19.4% | 9.1% | |
| 4.1% | 5.6% | 1.4% | 5.3% | 15.8% | 76.1% | 149.8% | 145.6% | -129.5% | -23.9% | -71.9% | 29.4% | |
| 14.0% | 14.8% | 10.0% | 12.5% | 29.5% | 106.4% | 199.5% | 191.2% | -160.2% | -24.5% | -83.5% | 48.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.